Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection
In this prospective cohort study, given a negative predictive value of 99.3%, a falling or negative titer may obviate the need for imaging, reducing radiation and contrast dye exposure. Conversely, a rising antibody titer should trigger closer follow-up, as it may lead to earlier detection of clinical recurrence and initiation of therapy.
Authors
- Tomoko Akaike (ORCID: https://orcid.org/0000-0003-4525-6408)
- Kristina Lachance (ORCID: https://orcid.org/0000-0002-2697-268X)
- Coley Doolittle‐Amieva
- Kelsey Cahill
- Daniel S. Hippe (ORCID: https://orcid.org/0000-0003-2427-4404)
- Song Youn Park
- Alex Z. Fu (ORCID: https://orcid.org/0000-0002-4020-6519)
- Lindsay Gunnell
- Paul Nghiem (ORCID: https://orcid.org/0000-0003-2784-963X)
Institutions
- University of Washington (US)
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.1001/jamadermatol.2025.3155
- Citations
- 2
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.09